NGS Automation Market Size, Share, Growth Analysis, By product type(Workstation/Robotic Platform, Reagents & Consumables), By application(Drug Discovery, Clinical Diagnostics, Other Applications), By sequencing type(Whole Genome, Exome, Targeted), By End use(Hospitals, Diagnostic Laboratories, Pharmaceutical, Academic), By Region - Industry Forecast 2024-2031

NGS Automation Market was valued at USD 2214.93 billion in 2022, and is poised to grow from USD 2543.85 billion in 2023, to USD 7700.86 Billion by 2031 at a CAGR of 14.85% during the forecast period (2024-2031).

High-throughput sequencing is another name for next-generation sequencing, which includes a number of cutting-edge sequencing technologies. As a result of these new technologies' ability to generate DNA and RNA more quickly, inexpensively, and without incurring as much expense as traditional ones, genomics and molecular biology research have been fundamentally altered. The NGS library preparation is automated using automated liquid handling devices known as NGS automation workstations. By producing consistent, dependable, and reproducible data, automation enables researchers to increase the quality of their library.

The procedure takes less time and is more cost-effective because of NGS automation. By minimising human contact with the chemicals and samples, it further lowers the risk of contamination. Since manual library preparation requires a lot of effort, there is a growing need for automation in the NGS workflow to improve productivity and lower error rates. The use of next-generation sequencing in drug development and the broad portfolio provided by major players are the two main factors fueling the growth of the global next-generation sequencing (NGS) market. On the other hand, the high cost of next-generation sequencing products and product recalls are two factors restraining the market's expansion.

US NGS Automation Market is poised to grow at a sustainable CAGR for the next forecast year.